We are live on ! Find out more
AKBA icon

Akebia Therapeutics
AKBA

61 hedge funds and large institutions have $88.2M invested in Akebia Therapeutics in 2015 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

64% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 14

7% more funds holding

Funds holding: 57 → 61 (+4)

7% less capital invested

Capital invested by funds: $94.4M → $88.2M (-$6.21M)

22% less call options, than puts

Call options by funds: $348K | Put options by funds: $445K

Holders
61
Holders Change
+4
Holders Change %
+7.02%
% of All Funds
1.63%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
10
Increased
23
Reduced
14
Closed
6
Calls
$348K
Puts
$445K
Net Calls
-$97K
Net Calls Change
-$381K

Top Buyers

1
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$2.74M
2
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$921K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$602K
4
ERSOT
Employees Retirement System of Texas
Texas
+$532K
5
EA
Emerald Advisers
Pennsylvania
+$457K

Top Sellers

1
HM
HealthCor Management
New York
-$2.67M
2
Millennium Management
Millennium Management
New York
-$1.01M
3
Franklin Resources
Franklin Resources
California
-$1.01M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$961K
5
CS
Candriam SCA
Luxembourg
-$890K
Name Holding Trade Value Shares
Change 		Change in
Stake
NHAS
1
Novo Holdings A/S
Denmark
$16.8M – – –
EAM
2
Eagle Asset Management
Florida
$13.8M +$168K +15,805 +1%
Stifel Financial
3
Stifel Financial
Missouri
$11.1M -$1.06K -100 -0%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$8.05M – – –
RCM
5
RA Capital Management
Massachusetts
$6.64M – – –
HM
6
HealthCor Management
New York
$6.61M -$2.67M -250,720 -30%
BFA
7
BlackRock Fund Advisors
California
$5.27M +$178K +16,739 +4%
Vanguard Group
8
Vanguard Group
Pennsylvania
$3.2M +$602K +56,517 +24%
EMFAT
9
Emerald Mutual Fund Advisers Trust
Pennsylvania
$2.12M +$2.74M +257,090 New
Balyasny Asset Management
10
Balyasny Asset Management
Illinois
$1.54M -$961K -90,258 -39%
State Street
11
State Street
Massachusetts
$1.15M +$49.8K +4,678 +5%
CAM
12
Cormorant Asset Management
Massachusetts
$1.11M -$188K -17,700 -15%
FWIA
13
Fort Washington Investment Advisors
Ohio
$1.04M – – –
Mirae Asset Global Investments
14
Mirae Asset Global Investments
South Korea
$961K +$921K +86,492 New
Northern Trust
15
Northern Trust
Illinois
$899K +$8.31K +781 +1%
BIT
16
BlackRock Institutional Trust
California
$819K -$8.57K -805 -1%
Morgan Stanley
17
Morgan Stanley
New York
$620K -$721K -67,710 -55%
ERSOT
18
Employees Retirement System of Texas
Texas
$556K +$532K +50,000 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$477K +$28.1K +2,640 +7%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$388K -$266 -25 -0.1%
EA
21
Emerald Advisers
Pennsylvania
$354K +$457K +42,910 New
BCM
22
Bridgeway Capital Management
Texas
$352K +$337K +31,650 New
TCIM
23
TIAA CREF Investment Management
New York
$321K – – –
CS
24
Credit Suisse
Switzerland
$309K +$85.8K +8,056 +41%
Connor, Clark & Lunn Investment Management (CC&L)
25
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$266K +$109K +10,200 +74%
1
2 3

AKBA Hedge Fund Activity: Q1 2015 in Review

61 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q1 2015, worth a combined $88.2M — down 6.6% from $94.4M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new AKBA positions and 6 closed out — a net gain of 4 holders — while 23 added to existing stakes and 14 trimmed.

The largest buyer was Emerald Mutual Fund Advisers Trust, opening a new position worth an estimated $2.74M. The largest seller was HealthCor Management, cutting an estimated $2.67M.

  • 61 institutional investors held Akebia Therapeutics (AKBA) as of Q1 2015, up from 57 in Q4 2014.
  • Funds reported $88.2M of Akebia Therapeutics stock for Q1 2015, down 6.6% quarter-over-quarter.
  • 10 funds opened new Akebia Therapeutics positions in Q1 2015 and 6 closed out, a net change of +4 holders.
  • The largest Akebia Therapeutics buyer in Q1 2015 was Emerald Mutual Fund Advisers Trust, an estimated $2.74M added.
  • The largest Akebia Therapeutics seller in Q1 2015 was HealthCor Management, an estimated $2.67M sold.

Based on aggregated 13F filings for Q1 2015.